Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Oncology

Search Medical Condition
Please enter condition
Please choose location

Thrombocytopenia and Thrombocytopenia Prevention Clinical Trials

A listing of Thrombocytopenia and Thrombocytopenia Prevention medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (3) clinical trials

Primary Objective: To compare efficacy of ruxolitinib versus anagrelide as measured by the proportion of subjects demonstrating platelet and white blood cell (WBC) control. Secondary Objectives: To evaluate the safety and tolerability of ruxolitinib compared with anagrelide in subjects with essential thrombocythemia (ET). To compare complete remission (CR) and partial ...


Prevention of Thrombocytopenia in Glioblastoma Patients

Chemotherapy used in the treatment of primitive tumors of the central nervous system has a particularly important platelet toxicity compared to chemotherapy used for treatment of other tumors. Chemotherapy postponed for toxicity is often due to thrombocytopenia (TP). The TP and/or the other anomalies of coagulation, which can be spontaneous ...


PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

Study Treatments: Epsilon aminocaproic acid (EACA) vs. standard prophylactic platelet transfusions. Study Title: Randomized Trial of Epsilon Aminocaproic Acid versus Platelet Transfusions for the Prevention of Bleeding in Thrombocytopenic Patients with Hematological Malignancies. (PROBLEMA trial: PRevention Of BLeeding in hEmatological Malignancies with Antifibrinolytic agents (epsilon aminocaproic acid). Phase: Randomized Phase ...